Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Stereotaxis Inc

+ Add to Watchlist

STXS:US

2.0800 USD 0.0100 0.48%

As of 20:10:00 ET on 03/27/2015.

Snapshot for Stereotaxis Inc (STXS)

Open: 2.0600 Day's Range: 2.0600 - 2.1300 Volume: 39,321
Previous Close: 2.0700 52wk Range: 1.3200 - 4.7400 1-Yr Rtn: -48.39%

Stock Chart for STXS

No chart data available.
  • STXS:US 2.0800
  • 1D
  • 1M
  • 1Y
2.0700
Interactive STXS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for STXS

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2689
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 43.12
Shares Outstanding (M) 20.73
30 Day Average Volume 209,848
Price/Book (mrq) -
Price/Sale (ttm) 1.1868
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for STXS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for STXS

Stereotaxis Inc. designs, manufactures and markets advanced cardiology instrument control system for use in the cath lab that is used in the treatment of coronary artery disease and arrhythmias. The company markets Stereotaxis System in the United States and Europe.

William C Mills IIIChairman/CEOMartin C StammerChief Financial Officer
Karen W DurosSenior VP/Secy/General CounselFrank J ChengSenior VP:Mktg & Business Dev
More Company Profile & Key Executives for STXS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil